FAQ Library

FAQ Library published on September 4, 2013
Dr. Paul Richardson discusses current trials that support the use of three-agent regimens as consolidation therapy to improve progression-free survival.
FAQ Library published on July 30, 2013 in Diagnosis/Staging
Dr. Philippe Moreau explains the role of the Bence-Jones test and what it measures when diagnosing multiple myeloma in a patient.
FAQ Library published on May 9, 2013 in Response Assessment, Comorbidities/SEs
Dr. Robert Orlowski discusses tips used at MD Anderson to ensure patients report all side effects related to their treatment.
FAQ Library published on May 9, 2013 in Induction Therapy, Emerging Therapeutics
Dr. Robert Orlowski explains the CyBorD regimen and its safety and efficacy as an induction therapy.
FAQ Library published on April 17, 2013 in Maintenance Therapy
Dr. Adam Cohen discusses treatment goals for maintenance therapy in myeloma.
FAQ Library published on March 6, 2013 in Response Assessment, General Education
Dr. Raphael Fonseca explains the criteria for a very good partial response in multiple myeloma.
FAQ Library published on March 6, 2013 in Response Assessment, General Education
Dr. Raphael Fonseca explains 'stable disease' in the multiple myeloma setting.
FAQ Library published on March 4, 2013 in Response Assessment, General Education
Dr. Raphael Fonseca explains the difference between complete response and stringent complete response in multiple myeloma.
FAQ Library published on January 9, 2013 in Stem Cell Transplant, Comorbidities/SEs
Dr. Sergio Giralt discusses how he manages side effects from stem cell transplantation.
FAQ Library published on January 9, 2013 in Stem Cell Transplant
Dr. Sergio Giralt discusses how he manages transplant eligible patients.
Page 7 of 13
Results 61 - 70 of 122